The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1/hVps34 complex.

Cancer Research
Xinqun Li, Zhen Fan

Abstract

Autophagy is a regulated catabolic process triggered in cells deprived of nutrients or growth factors that govern nutrient uptake. Here, we report that autophagy is induced by cetuximab, a therapeutic antibody that blocks epidermal growth factor receptor function. Cancer cell treatment with cetuximab triggered autophagosome formation, conversion of microtubule-associated protein 1 light chain 3 from its cytoplasmic to membrane-associated form, and increased acidic vesicular organelle formation. Autophagy occurred when cetuximab inhibited the class I phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin pathway, but not when it inhibited only the mitogen-activated protein/extracellular signal-regulated kinase kinase/Erk pathway, and it was accompanied by decreased levels of hypoxia inducible factor-1 alpha (HIF-1alpha) and Bcl-2. Stable overexpression of a HIF-1alpha mutant prevented cetuximab-induced autophagy and decrease in Bcl-2 levels. Knockdown of autophagy regulator beclin 1 or cell treatment with autophagy inhibitor 3-methyladenine, a class III PI3K (hVps34) inhibitor, also inhibited cetuximab-induced autophagy. Furthermore, knockdown of beclin 1 or Atg7 or treatment with the lysosome inhibitor chloroquine s...Continue Reading

References

Jun 6, 1995·Proceedings of the National Academy of Sciences of the United States of America·G L WangG L Semenza
Feb 23, 2000·FEBS Letters·E MinetC Michiels
Dec 2, 2000·Science·D J Klionsky, S D Emr
Aug 12, 2003·International Journal of Radiation Oncology, Biology, Physics·Ke LiangZhen Fan
Oct 11, 2003·Developmental Cell·Daniel J KlionskyYoshinori Ohsumi
Nov 26, 2003·The Journal of Clinical Investigation·Xueping QuBeth Levine
Dec 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·Zhenyu YueNathaniel Heintz
Apr 13, 2004·Oncogene·Devrim Gozuacik, Adi Kimchi
Nov 6, 2004·Science·Takahiro Shintani, Daniel J Klionsky
Jan 20, 2005·Molecular and Cellular Biology·Patricia BoyaGuido Kroemer
Jun 2, 2005·Nature Reviews. Molecular Cell Biology·Eric H Baehrecke
Jun 30, 2005·Journal of Cell Science·Rosa-Ana González-PoloGuido Kroemer
Sep 9, 2005·Nature Reviews. Cancer·Yasuko KondoSeiji Kondo
Sep 24, 2005·Cell·Sophie PattingreBeth Levine
Mar 21, 2006·Proceedings of the National Academy of Sciences of the United States of America·Li YuMichael Lenardo
Jun 27, 2006·Nature Cell Biology·Chengyu LiangJae U Jung
Jul 29, 2006·Autophagy·Yasuko Kondo, Seiji Kondo
Jul 29, 2006·Autophagy·Beth Levine
Jul 24, 2007·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Noriyuki KimuraRyuki Arakawa
Feb 19, 2008·The Journal of Biological Chemistry·Huafeng ZhangGregg L Semenza
Mar 26, 2008·Autophagy·Maria Høyer-Hansen, Marja Jäättelä
Jun 24, 2008·Molecular Cell·Yongjie WeiBeth Levine
Jan 28, 2009·Apoptosis : an International Journal on Programmed Cell Death·Avital Eisenberg-Lerner, Adi Kimchi

❮ Previous
Next ❯

Citations

Oct 24, 2012·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Alex ZhavoronkovAlexey Moskalev
May 29, 2012·Apoptosis : an International Journal on Programmed Cell Death·Boris K Pliyev, Mikhail Menshikov
Sep 1, 2012·Nature Reviews. Drug Discovery·David C RubinszteinBeth Levine
Jan 6, 2012·Molecular Pharmacology·Yong TangPaul Dent
Apr 18, 2013·Biochemistry. Biokhimii︠a︡·A A ParkhitkoE P Henske
Sep 17, 2013·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Yong-Chun WangXi-Qing Sun
Sep 1, 2011·Molecular Cancer Therapeutics·Zhineng J YangFrank A Sinicrope
Oct 24, 2012·Cancer Management and Research·Jennifer S CarewSteffan T Nawrocki
Dec 8, 2011·World Journal of Gastroenterology : WJG·Gui-Fang GuoLiang-Ping Xia
Jan 5, 2014·Molecular Neurobiology·Deepak ChhanganiAmit Mishra
Aug 8, 2014·Journal of the National Cancer Institute·Zhiyong WangJ Silvio Gutkind
Mar 16, 2013·Expert Opinion on Biological Therapy·Songshu MengChan Ding
Jun 6, 2015·International Journal of Oncology·Pyoung Rak ChoiNam Deuk Kim
Mar 22, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Betty Yuen Kwan LawVincent Kam Wai Wong
May 7, 2015·Bioconjugate Chemistry·Reyna K V LimStephanie A Kazane
Jan 26, 2011·Cancer Biology & Therapy·Zhineng J YangFrank Sinicrope
Jul 25, 2012·Cancer Biology & Therapy·Hidemi Rikiishi
Sep 8, 2012·Cancer Biology & Therapy·Christopher FungUmamaheswar Duvvuri
May 3, 2014·Seminars in Oncology·Joseph M CurryMadalina Tuluc
Oct 14, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Raquel T LimaM Helena Vasconcelos
Apr 22, 2017·Cellular Signalling·Hongsen LiWeidong Han
Sep 21, 2017·International Journal of Molecular Sciences·Daniel Ngabire, Gun-Do Kim
Jun 21, 2017·International Journal of Molecular Sciences·Ying-Ying LiNiramol Savaraj

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Autophagy Networks

Autophagy is a lysosomal pathway that involves degradation of proteins and functions in normal growth and pathological conditions, through a series of complex networks. The catabolic process involves delivery of proteins and organelles to the lysosome. Here is the latest research on autophagy networks.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.